Ali I. Al‐Gareeb
Impact in
- Biological Psychiatry top 1%
- Tryptophan and brain disorders
- Neurology top 0.5%
- Long-Term Effects of COVID-19
- Parkinson's Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- COVID-19 Clinical Research Studies 54
- SARS-CoV-2 and COVID-19 Research 14
- Co-authors
- Hayder M. Al‐kuraishy (251 shared papers)Gaber El‐Saber Batiha (175 shared papers)Αθανάσιος Αλεξίου (110 shared papers)Hebatallah M. Saad (49 shared papers)Marios Papadakis (91 shared papers)Ali K. Albuhadily (61 shared papers)Natália Martins (8 shared papers)Engy Elekhnawy (16 shared papers)
- Journals
- Inflammopharmacology (24 papers)Naunyn-Schmiedeberg s Archives of Pharmacology (12 papers)Journal of Cellular and Molecular Medicine (11 papers)Ageing Research Reviews (9 papers)Molecular Neurobiology (8 papers)
- Partner nations
- IraqEgyptSaudi Arabia
In The Last Decade
Ali I. Al‐Gareeb
344 papers receiving 7.4k citations
Ali I. Al‐Gareeb's Hit Papers
Peers
Comparison fields: 5 of 150
- Biological Psychiatry 286
- Neurology 1.3k
- Neurology 624
- Infectious Diseases 1.2k
- Physiology 1.2k
Countries citing papers authored by Ali I. Al‐Gareeb
This map shows the geographic impact of Ali I. Al‐Gareeb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali I. Al‐Gareeb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali I. Al‐Gareeb more than expected).
Fields of papers citing papers by Ali I. Al‐Gareeb
This network shows the impact of papers produced by Ali I. Al‐Gareeb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali I. Al‐Gareeb. The network helps show where Ali I. Al‐Gareeb may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali I. Al‐Gareeb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 360 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality Hit paper breakdown → | 2022 | 154 |
| 2 | 2019 | 121 | |
| 3 | 2021 | 94 | |
| 4 | 2021 | 91 | |
| 5 | 2023 | 90 | |
| 6 | 2022 | 85 | |
| 7 | 2021 | 80 | |
| 8 | 2022 | 78 | |
| 9 | 2022 | 73 | |
| 10 | 2022 | 71 | |
| 11 | 2021 | 71 | |
| 12 | 2022 | 66 | |
| 13 | 2023 | 64 | |
| 14 | 2021 | 63 | |
| 15 | 2022 | 62 | |
| 16 | 2023 | 61 | |
| 17 | 2023 | 61 | |
| 18 | 2020 | 61 | |
| 19 | 2022 | 61 | |
| 20 | 2018 | 60 |
About Ali I. Al‐Gareeb
Ali I. Al‐Gareeb is a scholar working on Molecular Biology, Infectious Diseases, Neurology, Physiology and Cellular and Molecular Neuroscience, having authored 360 papers that have together received 7.5k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (54 papers), Alzheimer's disease research and treatments (31 papers), Long-Term Effects of COVID-19 (31 papers), Parkinson's Disease Mechanisms and Treatments (25 papers), Nuclear Receptors and Signaling (15 papers), SARS-CoV-2 and COVID-19 Research (14 papers), Neuroinflammation and Neurodegeneration Mechanisms (13 papers) and Drug-Induced Hepatotoxicity and Protection (12 papers). The work is most often cited by research in Biological Psychiatry (286 citations), Neurology (1.3k citations), Neurology (624 citations), Infectious Diseases (1.2k citations) and Physiology (1.2k citations). Ali I. Al‐Gareeb has collaborated with scholars based in Iraq, Egypt and Saudi Arabia. Frequent co-authors include Hayder M. Al‐kuraishy, Gaber El‐Saber Batiha, Αθανάσιος Αλεξίου, Hebatallah M. Saad, Marios Papadakis, Ali K. Albuhadily, Natália Martins, Engy Elekhnawy, Thabat J. Al‐Maiahy and Majid S. Jabir. Their work appears in journals such as Inflammopharmacology, Naunyn-Schmiedeberg s Archives of Pharmacology, Journal of Cellular and Molecular Medicine, Ageing Research Reviews and Molecular Neurobiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.